Detalhe da pesquisa
1.
In Silico Transcriptomic Expression of MSR1 in Solid Tumors Is Associated with Responses to Anti-PD1 and Anti-CTLA4 Therapies.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612803
2.
Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.
Int J Mol Sci
; 25(10)2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791382
3.
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.
Int J Mol Sci
; 25(4)2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396898
4.
Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents.
Int J Mol Sci
; 24(18)2023 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762123
5.
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.
Int J Mol Sci
; 24(14)2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511178
6.
Clinical considerations for the design of PROTACs in cancer.
Mol Cancer
; 21(1): 67, 2022 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249548
7.
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.
Int J Mol Sci
; 23(10)2022 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628286
8.
Mithramycin delivery systems to develop effective therapies in sarcomas.
J Nanobiotechnology
; 19(1): 267, 2021 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488783
9.
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.
Int J Mol Sci
; 22(8)2021 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917174
10.
Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer.
J Cell Mol Med
; 24(5): 3117-3127, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032474
11.
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates.
Breast Cancer Res
; 22(1): 15, 2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005279
12.
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment.
Int J Mol Sci
; 21(17)2020 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32825618
13.
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
Int J Mol Sci
; 21(23)2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33261142
14.
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
Breast Cancer Res Treat
; 174(3): 693-701, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30607629
15.
Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer.
Breast Cancer Res Treat
; 172(3): 725-732, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30206781
16.
Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis.
Breast Cancer Res Treat
; 169(3): 413-425, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29423899
17.
Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer.
Breast Cancer Res Treat
; 168(3): 613-623, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330624
18.
Reporting of Randomized Trials in Common Cancers in the Lay Media.
Oncology
; 94(2): 65-71, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151109
19.
Neutrophils in cancer: prognostic role and therapeutic strategies.
Mol Cancer
; 16(1): 137, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28810877
20.
Prognostic role of telomere length in malignancies: A meta-analysis and meta-regression.
Exp Mol Pathol
; 102(3): 455-474, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28506770